Montag A & Associates Inc Abbott Laboratories Transaction History

Montag A & Associates Inc

  • $1.97 Billion
  • Q2 2024

A detailed history of Montag A & Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Montag A & Associates Inc holds 110,263 shares of ABT stock, worth $12.4 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
110,263
Previous 122,684 10.12%
Holding current value
$12.4 Million
Previous $13.9 Million 17.84%
% of portfolio
0.58%
Previous 0.7%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
SELL
$100.73 - $112.44 $1.25 Million - $1.4 Million
-12,421 Reduced 10.12%
110,263 $11.5 Million
Q1 2024

May 07, 2024
SELL
$109.52 - $120.96 $845,384 - $933,690
-7,719 Reduced 5.92%
122,684 $13.9 Million
Q4 2023

Feb 07, 2024
BUY
$90.19 - $110.4 $341,369 - $417,864
3,785 Added 2.99%
130,403 $14.4 Million
Q3 2023

Nov 09, 2023
BUY
$95.53 - $114.62 $1.06 Million - $1.28 Million
11,126 Added 9.63%
126,618 $12.3 Million
Q2 2023

Aug 09, 2023
BUY
$100.78 - $112.29 $904,903 - $1.01 Million
8,979 Added 8.43%
115,492 $12.6 Million
Q1 2023

May 11, 2023
SELL
$96.86 - $114.01 $43,974 - $51,760
-454 Reduced 0.42%
106,513 $10.8 Million
Q4 2022

Feb 02, 2023
SELL
$95.06 - $111.52 $2 Million - $2.35 Million
-21,062 Reduced 16.45%
106,967 $11.7 Million
Q3 2022

Nov 09, 2022
SELL
$96.76 - $112.03 $745,826 - $863,527
-7,708 Reduced 5.68%
128,029 $12.4 Million
Q2 2022

Aug 10, 2022
SELL
$102.07 - $123.37 $258,237 - $312,126
-2,530 Reduced 1.83%
135,737 $14.7 Million
Q1 2022

May 02, 2022
BUY
$114.02 - $139.04 $984,676 - $1.2 Million
8,636 Added 6.66%
138,267 $16.4 Million
Q4 2021

Feb 09, 2022
SELL
$115.53 - $141.46 $18,484 - $22,633
-160 Reduced 0.12%
129,631 $18.2 Million
Q3 2021

Nov 08, 2021
BUY
$116.66 - $129.06 $2.13 Million - $2.36 Million
18,264 Added 16.38%
129,791 $15.3 Million
Q2 2021

Aug 03, 2021
SELL
$105.79 - $124.53 $2.36 Million - $2.78 Million
-22,337 Reduced 16.69%
111,527 $12.9 Million
Q1 2021

May 14, 2021
BUY
$108.84 - $128.23 $587,953 - $692,698
5,402 Added 4.21%
133,864 $16 Million
Q4 2020

Feb 12, 2021
BUY
$105.0 - $114.42 $2.06 Million - $2.24 Million
19,604 Added 18.01%
128,462 $14.1 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $801,391 - $973,231
8,745 Added 8.74%
108,858 $11.8 Million
Q2 2020

Aug 04, 2020
SELL
$76.57 - $98.0 $3.44 Million - $4.4 Million
-44,896 Reduced 30.96%
100,113 $9.15 Million
Q1 2020

May 06, 2020
BUY
$62.82 - $91.86 $742,029 - $1.09 Million
11,812 Added 8.87%
145,009 $11.4 Million
Q4 2019

Feb 05, 2020
BUY
$78.51 - $87.4 $623,761 - $694,393
7,945 Added 6.34%
133,197 $11.6 Million
Q3 2019

Nov 04, 2019
BUY
$81.84 - $88.74 $1.48 Million - $1.6 Million
18,040 Added 16.83%
125,252 $10.5 Million
Q2 2019

Aug 06, 2019
BUY
$72.88 - $85.0 $2.8 Million - $3.26 Million
38,403 Added 55.81%
107,212 $9.02 Million
Q1 2019

May 01, 2019
SELL
$66.22 - $80.06 $3.24 Million - $3.91 Million
-48,900 Reduced 41.54%
68,809 $5.5 Million
Q4 2018

Feb 06, 2019
BUY
$65.56 - $74.27 $351,794 - $398,532
5,366 Added 4.78%
117,709 $8.51 Million
Q3 2018

Nov 07, 2018
BUY
$60.81 - $73.36 $3.07 Million - $3.7 Million
50,411 Added 81.4%
112,343 $8.24 Million
Q2 2018

Aug 01, 2018
SELL
$57.57 - $63.54 $86,355 - $95,310
-1,500 Reduced 2.36%
61,932 $3.78 Million
Q1 2018

May 07, 2018
BUY
$56.27 - $63.62 $84,405 - $95,430
1,500 Added 2.42%
63,432 $3.8 Million
Q3 2017

Nov 06, 2017
BUY
$48.06 - $53.64 $2.98 Million - $3.32 Million
61,932
61,932 $3.31 Million

Others Institutions Holding ABT

# of Institutions
3,135
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email